Hydroxychloroquine for Treatment of Non-Severe COVID-19
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Currently there are no proven treatments for COVID-19 and current standard therapy is
supportive care with oxygen supplementation and treatment of symptoms. Several re-purposed
and new drugs have been investigated but none is conclusive for efficacy against COVID-19
.Both Hydroxychloroquine(HCQ) and Chloroquine(CQ) have demonstrated activity against severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and have been investigated in small
clinical trials with contradicting reports on their benefits or harm in treatment of COVID-19
.Several authors agree that the use of HCQ for treatment of COVID-19 needs to be assessed in
large randomized controlled trials